Measles started as an animal virus. The measles virus evolved from rinderpest, a closely related virus that infected cattle, and jumped to humans roughly 2,500 years ago when growing cities created the conditions for it to spread and survive in human populations. That jump from cattle to people marks the true beginning of measles as a human disease.
The Jump From Cattle to Humans
Measles belongs to a family of viruses called morbilliviruses, which also cause rinderpest in cattle and sheep, distemper in dogs and cats, and epidemic diseases in dolphins and seals. The measles virus diverged from the rinderpest virus around the 6th century BCE, likely through repeated close contact between humans and domesticated cattle. Early agricultural societies lived alongside their livestock in tight quarters, giving the virus plenty of opportunities to cross the species barrier.
A 2020 study in Science pushed the estimated emergence date back further than previously thought. Earlier research had placed the jump in the 11th or 12th century CE, but molecular clock analysis of older virus samples concluded that measles likely entered the human population as early as the 4th century BCE. That timing lines up with a critical threshold: cities were finally becoming large enough to keep the virus circulating permanently.
Why Measles Needed Cities to Survive
Measles can only sustain itself in large, dense populations. Studies of island communities found that measles transmission broke down in every population under 500,000 people. Below that number, the virus would burn through susceptible individuals, run out of new hosts, and die out. It needed a constant supply of people who hadn’t been infected yet, which in practice meant a constant supply of newborns.
This is why measles couldn’t have become a permanent human disease during the hunter-gatherer era or even in small farming villages. It required the dense, growing cities of the ancient world. Non-human primates can catch measles, but their population sizes fall far below this critical threshold, so the virus never established itself in wild animal populations either. Once ancient cities in Mesopotamia, Egypt, India, and China crossed the population threshold, measles had a permanent home.
How the Virus Infects the Body
Measles is extraordinarily contagious. The virus travels through the air as tiny droplets and remains infectious for up to two hours after an infected person leaves a room. You don’t need direct contact with a sick person. Walking into a space they occupied an hour earlier is enough.
Once inhaled, the virus latches onto immune cells in the respiratory tract using a specific receptor found on activated immune cells. This is what makes measles so devastating: it targets the very cells your body sends to fight it. From there, the virus spreads to epithelial cells lining the trachea, lungs, mouth, throat, and even the intestines, liver, and bladder. It uses a second receptor found on those epithelial surfaces to gain entry. This two-receptor strategy, hitting both immune cells and the tissues lining your airways, explains why measles causes such widespread symptoms and why it suppresses the immune system for weeks or months after infection.
The First Medical Description
Measles circulated for well over a thousand years before anyone wrote a clear clinical account of it. The Persian physician Al-Razi, known in the West as Rhazes, produced the first detailed description around 900 CE. His challenge was distinguishing measles from smallpox, since both caused fever and skin eruptions.
Al-Razi noted that both diseases shared early symptoms: continuous fever, nose itching, redness of the cheeks and eyes, sore throat, chest pain, breathing difficulties, and cough. But he identified key differences. Back pain was more severe in smallpox and slight or absent in measles. Distress, fainting, and anxiety were more prominent in measles. The rashes looked different too: measles appeared as flat red spots that didn’t rise above or sink below the skin surface, while smallpox eruptions infiltrated the skin. Critically, he observed that smallpox eruptions appeared in patches over several days, while measles spots appeared all over the body at once. These distinctions held up remarkably well over the following centuries.
Pre-Vaccine Devastation
Before a vaccine existed, measles killed an estimated 2.6 million people every year worldwide. Major epidemics swept through populations every two to three years, timed to the buildup of new susceptible children born since the last outbreak. In communities with no prior exposure, such as island populations or Indigenous peoples encountering European colonizers, mortality rates were catastrophic.
The virus wasn’t just deadly on its own. By suppressing the immune system, it left survivors vulnerable to pneumonia, diarrheal diseases, and other infections for weeks afterward. Many measles deaths were actually caused by these secondary infections hitting a body with temporarily crippled defenses.
Isolation of the Virus and Vaccine Development
In 1954, John F. Enders and Thomas C. Peebles collected blood samples from students during a measles outbreak in Boston, Massachusetts. They succeeded in isolating the virus from the blood of a 13-year-old named David Edmonston. That viral sample, called the Edmonston strain, became the foundation for vaccine development.
Enders, often called the father of modern vaccines, developed a weakened version of the virus from the “Edmonston-B” strain. By 1961, trials showed it was 100 percent effective at preventing measles. The first measles vaccine was licensed for public use in 1963. The Edmonston-B strain remains the basis for most live-attenuated measles vaccines used around the world today, including the combination MMR vaccine given to children in dozens of countries.
The trajectory from cattle virus to global killer to vaccine-preventable disease spans roughly 2,500 years. Measles went from a rinderpest variant exploiting the first large human cities to one of the most contagious diseases ever known, and then, within a single decade of laboratory work, to a disease that no longer needed to kill millions each year.